Exosome Secretion Drives Chemo‐Resistance of Temozolomide in Glioblastoma
ABSTRACT Temozolomide (TMZ) is a first‐line chemotherapeutic agent for the treatment of glioblastoma (GBM), while a majority of patients do not effectively respond to TMZ owing to the multiple resistance mechanisms. In this study, we found that TMZ treatment substantially increased the exosome secre...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2026-07-01
|
| Serier: | Journal of Extracellular Biology |
| Online adgang: | https://doi.org/10.1002/jex2.70161 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|